Fig. 1.

Algorithm for the treatment of acute mild-to-moderate atopic dermatitis (AD) or continuous mild AD in children, adolescents, and adults in South and East Asia. Single dagger superscript (^†) indicates topical calcineurin inhibitors (TCI): pimecrolimus 1% cream, or tacrolimus 0.1% (aged ≥ 16 years) or 0.03% (aged 2–15 years) ointment; pimecrolimus is not indicated for severe AD and tacrolimus is not indicated for mild AD. Double dagger superscript (^‡) indicates use of topical corticosteroids (TCS) that should be reserved for severe disease flares, but brief treatment with TCS may be considered if inflammation persists despite treatment with TCI